{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:46Z","timestamp":1761630646782,"version":"3.40.4"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":874,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Australasian Journal of Dermatology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1111\/ajd.12042","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T09:48:36Z","timestamp":1365587316000},"page":"296-302","source":"Crossref","is-referenced-by-count":16,"title":["Mycophenolate use in dermatology: A clinical audit"],"prefix":"10.1111","volume":"54","author":[{"given":"Jane","family":"Li","sequence":"first","affiliation":[{"name":"Department of Dermatology; St. Vincent's Hospital Melbourne; Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin H","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Dermatology; St. Vincent's Hospital Melbourne; Melbourne Victoria Australia"},{"name":"Skin and Cancer Foundation Inc.; Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Dermatology; St. Vincent's Hospital Melbourne; Melbourne Victoria Australia"},{"name":"Skin and Cancer Foundation Inc.; Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Dermatology; St. Vincent's Hospital Melbourne; Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Dermatology; St. Vincent's Hospital Melbourne; Melbourne Victoria Australia"},{"name":"Skin and Cancer Foundation Inc.; Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"10.1111\/ajd.12042-BIB0001|ajd12042-cit-0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0012.1996.tb00651.x","article-title":"Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)","volume":"10","author":"Allison","year":"1996","journal-title":"Clin. Transplant."},{"key":"10.1111\/ajd.12042-BIB0002|ajd12042-cit-0002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/1523-1747.ep12610346","article-title":"Treatment of psoriasis with oral mycophenolic acid","volume":"65","author":"Jones","year":"1975","journal-title":"J. Invest. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0003|ajd12042-cit-0003","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015828802490","article-title":"Bioavailability improvement of mycophenolic acid through amino ester derivatization","volume":"7","author":"Lee","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1111\/ajd.12042-BIB0004|ajd12042-cit-0004","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/S0041-1345(01)02377-6","article-title":"Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate","volume":"33","author":"Bjarnason","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1111\/ajd.12042-BIB0005|ajd12042-cit-0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0738-081X(02)00271-7","article-title":"New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications","volume":"20","author":"Assmann","year":"2002","journal-title":"Clin. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0006|ajd12042-cit-0006","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1529-8019.2007.00136.x","article-title":"Mycophenolate mofetil","volume":"20","author":"Zwerner","year":"2007","journal-title":"Dermatol. Ther."},{"key":"10.1111\/ajd.12042-BIB0007|ajd12042-cit-0007","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09546630310016826","article-title":"Mycophenolate in dermatology","volume":"14","author":"Liu","year":"2003","journal-title":"J. Dermatolog. Treat."},{"key":"10.1111\/ajd.12042-BIB0008|ajd12042-cit-0008","first-page":"159","article-title":"Mycophenolate mofetil; a review of indications and use in a large tertiary hospital","volume":"4","author":"Geevasinga","year":"2005","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1111\/ajd.12042-BIB0009|ajd12042-cit-0009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09546630410020154","article-title":"Mycophenolate mofetil in pyoderma gangrenosum","volume":"15","author":"Lee","year":"2004","journal-title":"J. Dermatolog. Treat."},{"key":"10.1111\/ajd.12042-BIB0010|ajd12042-cit-0010","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archderm.134.12.1509","article-title":"The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum","volume":"134","author":"Nousari","year":"1998","journal-title":"Arch. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0011|ajd12042-cit-0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0012|ajd12042-cit-0012","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000226134","article-title":"A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis","volume":"219","author":"Beissert","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/ajd.12042-BIB0013|ajd12042-cit-0013","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2146\/ajhp100227","article-title":"Advances in the treatment of moderate-to-severe plaque psoriasis","volume":"68","author":"Herrier","year":"2011","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1111\/ajd.12042-BIB0014|ajd12042-cit-0014","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1468-3083.2010.03667.x","article-title":"Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis","volume":"24","author":"Akhyani","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1111\/ajd.12042-BIB0015|ajd12042-cit-0015","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0016|ajd12042-cit-0016","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0017|ajd12042-cit-0017","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2010.04.027","article-title":"Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial","volume":"64","author":"Haeck","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0018|ajd12042-cit-0018","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.2001.04088.x","article-title":"Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients","volume":"144","author":"Geilen","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0019|ajd12042-cit-0019","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mjd.2001.114297","article-title":"Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil","volume":"45","author":"Goyal","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0020|ajd12042-cit-0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.139.6.739","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil","volume":"139","author":"Mimouni","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0021|ajd12042-cit-0021","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2007.07826.x","article-title":"Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy","volume":"156","author":"Kreuter","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0022|ajd12042-cit-0022","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1365-4632.2007.02975.x","article-title":"Panarteritis cutanea benigna - an entity limited to the skin or cutaneous presentation of a systemic necrotizing vasculitis? Report of seven cases and review of the literature","volume":"46","author":"Rogalski","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0023|ajd12042-cit-0023","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.2005.06445.x","article-title":"Chronic actinic dermatitis treated with mycophenolate mofetil","volume":"152","author":"Thomson","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0024|ajd12042-cit-0024","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1067\/mjd.2002.125080","article-title":"Use of mycophenolate mofetil in erythema nodosum","volume":"47","author":"Boyd","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0025|ajd12042-cit-0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2011.06.004","article-title":"The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients","volume":"66","author":"Zimmerman","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0026|ajd12042-cit-0026","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/kel244","article-title":"Mycophenolate mofetil in diffuse cutaneous systemic sclerosis - a retrospective analysis","volume":"46","author":"Nihtyanova","year":"2007","journal-title":"Rheumatology"},{"key":"10.1111\/ajd.12042-BIB0027|ajd12042-cit-0027","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0190-9622(03)02111-X","article-title":"Treatment of severe lichen planus with mycophenolate mofetil","volume":"49","author":"Frieling","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0028|ajd12042-cit-0028","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/archderm.138.12.1547","article-title":"Recurrent erythema multiforme\/Stevens-Johnson syndrome: response to mycophenolate mofetil","volume":"138","author":"Davis","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0029|ajd12042-cit-0029","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.134.3.378","article-title":"Dyshidrotic eczema treated with mycophenolate mofetil","volume":"134","author":"Pickenacker","year":"1998","journal-title":"Arch. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0030|ajd12042-cit-0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0190-9622(99)70203-3","article-title":"Mycophenolate mofetil in autoimmune and inflammatory skin disorders","volume":"40","author":"Nousari","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0031|ajd12042-cit-0031","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2133.2003.05042.x","article-title":"Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis","volume":"148","author":"Kouba","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0032|ajd12042-cit-0032","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0041-1345(01)01968-6","article-title":"Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience","volume":"33","author":"Basara","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1111\/ajd.12042-BIB0033|ajd12042-cit-0033","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","article-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","volume":"142","author":"Williams","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0034|ajd12042-cit-0034","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1365-2133.1999.03176.x","article-title":"Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting","volume":"141","author":"Schattenkirchner","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0035|ajd12042-cit-0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mjd.2001.114746","article-title":"Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent","volume":"45","author":"Megahed","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0036|ajd12042-cit-0036","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0037|ajd12042-cit-0037","unstructured":"British Association of Dermatologists Mycophenolate mofetil 2008 http:\/\/www.bad.org.uk\/site\/1126\/Default.aspx"},{"key":"10.1111\/ajd.12042-BIB0038|ajd12042-cit-0038","first-page":"18","article-title":"The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room","volume":"4","author":"Park","year":"2011","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"10.1111\/ajd.12042-BIB0039|ajd12042-cit-0039","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.106.012013","article-title":"Gender-related differences in mycophenolate mofetil-induced gastrointestinal toxicity in rats","volume":"35","author":"Stern","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/ajd.12042-BIB0040|ajd12042-cit-0040","unstructured":"Roche CellCept capsule data sheet 2012 http:\/\/www.medsafe.govt.nz\/profs\/Datasheet\/c\/Cellceptcapsuspinf.pdf"},{"key":"10.1111\/ajd.12042-BIB0041|ajd12042-cit-0041","first-page":"1","article-title":"Mycophenolate mofetil: a dermatologic perspective","volume":"10","author":"Mydlarski","year":"2005","journal-title":"Skin Therapy Lett."},{"key":"10.1111\/ajd.12042-BIB0042|ajd12042-cit-0042","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.1977.01640090051004","article-title":"Mycophenolic acid for psoriasis","volume":"113","author":"Lynch","year":"1977","journal-title":"Arch. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0043|ajd12042-cit-0043","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1177\/0961203306071431","article-title":"Primary lymphoma of CNS, mycophenolate mofetil and lupus","volume":"15","author":"Finelli","year":"2006","journal-title":"Lupus"},{"key":"10.1111\/ajd.12042-BIB0044|ajd12042-cit-0044","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.jaad.2004.03.020","article-title":"Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate","volume":"51","author":"Waldman","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0045|ajd12042-cit-0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaad.2008.08.049","article-title":"Mycophenolate mofetil in dermatology","volume":"60","author":"Orvis","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12042-BIB0046|ajd12042-cit-0046","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.transproceed.2008.12.013","article-title":"Significant risk factors for occurrence of cancer after renal transplantation: a single center cohort study of 1265 cases","volume":"41","author":"Bichari","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1111\/ajd.12042-BIB0047|ajd12042-cit-0047","first-page":"741","article-title":"Long-term safety of mycophenolate mofetil and cyclosporine: a review","volume":"7","author":"Buell","year":"2008","journal-title":"J. Drugs Dermatol."},{"key":"10.1111\/ajd.12042-BIB0048|ajd12042-cit-0048","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil","volume":"5","author":"Robson","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1111\/ajd.12042-BIB0049|ajd12042-cit-0049","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug. Saf."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajd.12042","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajd.12042\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:58:11Z","timestamp":1745985491000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.12042"}},"subtitle":["Mycophenolate audit"],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1111\/ajd.12042","relation":{},"ISSN":["0004-8380"],"issn-type":[{"type":"print","value":"0004-8380"}],"subject":[],"published":{"date-parts":[[2013,4,10]]}}}